Skip to content
Stop using now Drug recall · FDA · Published July 17, 2026

Sunny Pharmtech Cyclophosphamide Injection Recall: Stainless Steel Particulates

Sunny Pharmtech recalls Cyclophosphamide injection vials due to stainless steel particles that could cause serious injury. Affected vials were manufactured in Taiwan with specific lot numbers.

🇺🇸 FDA recall #D-0744-2026DrugSunny Pharmtech ›
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sunny Pharmtech is recalling Cyclophosphamide injection vials that may contain stainless steel particles. This could cause serious injury if the particles enter the bloodstream during injection. Read more at govinfonow.com/recall/309276-sunny-pharmtech-cyclophosphamide-injection-recall-stainless-steel-particulates.

Source Summary by GovInfoNow · govinfonow.com/recall/309276-sunny-pharmtech-cyclophosphamide-injection-recall-stainless-steel-particulates · Updated August 18, 2026 · FDA enforcement record: FDA #D-0744-2026

Cite this page

“Sunny Pharmtech Cyclophosphamide Injection Recall: Stainless Steel Particulates.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/309276-sunny-pharmtech-cyclophosphamide-injection-recall-stainless-steel-particulates. Based on FDA recall #D-0744-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0744-2026%22&limit=1).

Why it’s dangerous

Stainless steel particles can enter the bloodstream during injection, potentially causing serious injury or death. This risk occurs because the particles are not properly filtered from the injection solution.

Who’s affected

Prescription patients using Cyclophosphamide injections for cancer treatment. Those with the specific lot numbers and manufacturing details listed are most at risk.

How to tell if you have this one

Check for vials labeled 'Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only'. Look for lot number V24010V1 and expiration date 3/31/2027.

  • Brand
    Sunny Pharmtech
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Ongoing
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsQuantity
D-0743-2026Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1; Lot # C23019V1, Exp 10/31/2026; C24015V1, Exp 4/30/20274,077 vials
D-0744-2026Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1; Lot # V24010V1, Exp 3/31/20271,464 vials
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately discard the vial if it contains stainless steel particles that could cause serious injury.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Jul 17, 202612. FDA classified it Class I: Aug 7, 202623. Published in FDA’s Enforcement Report: Aug 12, 202634. Added to GovInfoNow: Aug 18, 202642026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product manufactured?

Manufactured in Taiwan by Sunny Pharmtech for Long Grove Pharmaceuticals, LLC.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0744-2026 (July 17, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0744-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA